Risk factors for peritoneal dissemination of colorectal cancer

被引:52
|
作者
Yang, SH
Lin, JK
Lai, CR
Chen, CC
Li, AFY
Liang, WY
Jiang, JK
机构
[1] Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan
[3] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
关键词
colorectal cancer; peritoneal dissemination; cytology; risk factors;
D O I
10.1002/jso.20109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: The aim of this study was to clarify the risk factors associated with positive peritoneal dissemination (PPD) of colorectal cancer (CRC). Methods: From June 2000 to September 2002, 143 CRC patients who underwent elective curative (79.0%) or non-curative (21.0%) open laparotomy were prospectively studied. Clinical evaluations including classical factors, colonoscopic evaluation, intraoperative evaluation, and pathological features were recorded. PPD was diagnosed when macro- (MAPD) or microscopic peritoneal dissemination (MIPD) was evident. Positive peritoneal cytology from initially existing ascites or washing lavage indicated MIPD. Various factors were analyzed with univariate (Chi-square test) and then multivariate analyses (logistic regression test) to search for the risk factors of PPD. Results: Overall, MIPD, MAPD, and PPD were found in 2.8%, 6.3%, and 9.1%, respectively. Univariate analysis identified age (less than or equal to59 years), CA19-9 (greater than or equal to34.6 U/ml), poor differentiation, circumferential involvement (greater than or equal to3 quadrants), ascites volume (>80 ml), pN+, and pT4 as risk factors of PPD. PPD did not occur in patients with well-differentiated tumors, less circumferential involvement (<2 quadrants), or no lymph node metastasis. After multivariate analysis, CA19-9 (Odds ratio (95% CI), 8.6 (1.7-43.1)), pT4 (9.0 (1.3-61.0)), and age (5.26 (1.1-25.0)) remained significant risk factors. Conclusion: CA19-9 (greater than or equal to34.6 U/ml), pT4, and age (less than or equal to59 years) were significant risk factors of PPD. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 50 条
  • [21] Prognostic Impact of Macroscopic Complete Resection and Inflammatory Status for Colorectal Cancer With Peritoneal Dissemination
    Yamaguchi, Satoru
    Ihara, Keisuke
    Shida, Yosuke
    Yokoyama, Haruka
    Ogata, Hideo
    Nakajima, Masanobu
    Sasaki, Kinro
    Tsuchioka, Takashi
    Kato, Hiroyuki
    INTERNATIONAL SURGERY, 2018, 103 (7-8) : 331 - 338
  • [22] Cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis dissemination from colorectal cancer
    Turner, Keli
    Alexander, H. Richard, Jr.
    COLORECTAL CANCER, 2012, 1 (02) : 125 - 135
  • [23] INTRAPERITONEAL HYPERTHERMIC TREATMENT FOR PERITONEAL DISSEMINATION OF COLORECTAL CANCERS
    YAMAGUCHI, A
    TSUKIOKA, Y
    FUSHIDA, S
    KUROSAKA, Y
    KANNO, M
    YONEMURA, Y
    MIWA, K
    MIYAZAKI, I
    DISEASES OF THE COLON & RECTUM, 1992, 35 (10) : 964 - 968
  • [24] Genetic risk factors in colorectal cancer
    Bonaïti-Pellié, C
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1999, 8 : S27 - S32
  • [25] Epidemiology and risk factors for colorectal cancer
    Sandler, RS
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1996, 25 (04) : 717 - +
  • [26] Risk factors in the developing of colorectal cancer
    Butorin, G.
    Mingazov, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 295 - 295
  • [27] Dietary factors and risk of colorectal cancer
    Willett, WC
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 5 - 6
  • [28] Colorectal cancer epidemiology and risk factors
    Chetroiu, Diana
    Pop, Corina S.
    Diaconui, Sorina
    Beuran, Mircea
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2021, 124 (03) : 388 - 392
  • [29] Colorectal Cancer: Familial Risk Factors
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2025, 150 (05) : 185 - 185
  • [30] Risk Factors for the Diagnosis of Colorectal Cancer
    Lewandowska, Anna
    Rudzki, Grzegorz
    Lewandowski, Tomasz
    Stryjkowska-Gora, Aleksandra
    Rudzki, Slawomir
    CANCER CONTROL, 2022, 29